James B. Kaper is a Professor and Chair of the Department of Microbiology & Immunology at the University of Maryland School of Medicine. He serves as Vice Dean for Academic Affairs and previously held leadership roles as Senior Associate Dean (2014–2019) and Chair (2007–present). His research focuses on the molecular pathogenesis of diarrheagenic Escherichia coli and Vibrio cholerae , including vaccine development and bacterial-host interactions. Education: BS (1973) and PhD (1979) in Microbiology from University of Maryland; Postdoc in Molecular Pathogenesis at University of Washington (1979–1981) Dr. Kaper’s work has led to the creation of live attenuated cholera vaccines, including CVD 103-HgR, the first licensed recombinant bacterial vaccine. His lab investigates bacterial genetics, intestinal colonization, and immune system activation, particularly TLR5 response to V. cholerae flagellin. He has authored 303 peer-reviewed articles and 68 book chapters. His research has been funded continuously by NIAID since 1982. Key publications include foundational work on V. cholerae vaccines (1984), genomic structure (1998), and quorum sensing in EHEC/EPEC (1999). His lab’s recent studies focus on phosphotyrosine proteomics (2013) and pathogenicity island regulation (2007). Scientific awards: Fellow, American Academy of Microbiology (1994); NIH Merit Award (2004); ASM DC White Award (2019) Editorial roles: Editor-in-Chief, EcoSal (2006–present); Associate Editor, International Journal of Medical Microbiology (2000–present) As an academic leader, Dr. Kaper has mentored over 60 graduate students and postdoctoral fellows. He holds multiple patents for cholera vaccines and E. coli diagnostics, including U.S. Patents 4,935,364; 5,399,494; and 6,204,004. His lab at UMSOM combines basic science with translational applications for enteric disease prevention.
Manuel R. Amieva is a Professor at Stanford University School of Medicine , holding joint appointments in Pediatrics - Infectious Diseases and Microbiology & Immunology . He is also a member of the Maternal & Child Health Research Institute (MCHRI) . His clinical practice at Stanford Medicine Children's Health focuses on pediatric infectious diseases. Education: Medical Education: Stanford University School of Medicine (1997) Fellowship: Stanford University Pediatric Infectious Disease Fellowship (2004) Internship & Residency: Stanford Health Care at Lucile Packard Children's Hospital (1998-1999) Dr. Amieva's research investigates host-pathogen interactions at epithelial barriers, with specific expertise in Helicobacter pylori , Listeria monocytogenes , Salmonella enterica , and Staphylococcus aureus . His lab develops innovative organoid culture systems with controlled polarity to study microbial colonization and oncogenic mechanisms. Key discoveries include: H. pylori's manipulation of epithelial junctions via the CagA protein Listeria's exploitation of cell extrusion sites for invasion Staphylococcus toxin interactions with adherens junctions Gastric stem cell activation by pathogens Recent publication trends show continued leadership in infectious disease mechanisms (2020-2025), with a focus on: Pathogen-specific epithelial breach strategies Organoid modeling of viral/bacterial interactions Redox-dependent host factor regulation Single-cell spatial transcriptomic analyses Multi-institutional educational frameworks His scientific collaborations span disciplines including: Gastric cancer genomics initiatives COVID-19 lung infection models Stem cell-microbe interactions Medical education reform projects Dr. Amieva maintains active clinical research while mentoring students in both the Microbiology & Immunology and Pediatrics programs. His lab at Stanford employs advanced 3D confocal microscopy and organ-on-a-chip technologies to visualize epithelial colonization dynamics.
Professor Francis Butler is a Full Professor at University College Dublin's School of Biosystems and Food Engineering, where he has been since 1990. His academic roles include research leadership in food safety, food chain integrity, and microbial risk assessment. He leads the UCD Institute for Food and Health and the UCD Centre for Food Safety as a Principal Investigator. Education: BE, Grad Dip University Teaching & Learning, MBA, and PhD from University College Dublin. Research Focus: His work centers on food safety hazards, quantitative risk assessment, and next-generation sequencing for pathogen identification. Recent projects include Listeria monocytogenes growth modeling, norovirus in oysters, and hepatitis E in pork products. He has secured over €6 million in research grants, including EU-funded projects like FOODINTEGRITY and SIGMACHAIN. Awards & Recognition: European Food Safety Authority Fellowship, Marie Sklodowska-Curie Fellowship, and UCD Teaching Grant. He coordinates international educational programs, including the UCD MSC Food Safety and Risk Analysis. Professional Activities: Member of EFSA advisory committees, editorial boards (e.g., Microbial Risk Analysis ), and international conference chairs. His work bridges academia, industry, and policy to enhance food safety standards globally.
William John Moss is a Professor in the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health, where he also holds joint appointments in International Health and Molecular Microbiology and Immunology. He serves as Executive Director of the International Vaccine Access Center (IVAC) and Deputy Director at the Johns Hopkins Malaria Research Institute. His work spans multiple centers including the Center for Global Health, Center for Humanitarian Health, and Johns Hopkins Vaccine Initiative. Dr. Moss earned his MD from Columbia University in 1984 and his MPH in 1995. As a pediatrician with subspecialty training in infectious diseases, he has conducted extensive field research across multiple countries including Ethiopia, Kenya, South Africa, Zambia, Zimbabwe and India. His research focuses on the epidemiology and control of childhood infections in resource-poor settings, with particular emphasis on measles-HIV interactions, malaria transmission in southern Africa, serosurveillance for immunization programs, and care of HIV-infected children in rural Zambia. His recent work (2024-2025) demonstrates continued focus on measles epidemiology, malaria transmission dynamics, and vaccine implementation research, with numerous publications examining immunity gaps, human mobility patterns, and malaria vector biology in African settings. Scientific Awards: Wyeth-Lederle Vaccines and Pediatrics Young Investigator Award in Vaccine Development (1999-2001) Gustave J. Martin Innovative Research Fund Fellow (2001) Advising, Mentoring and Teaching Recognition Award (2007-2008) Dr. Moss leads multiple research projects including studies on HIV-infected children's immune reconstitution, malaria transmission dynamics in southern Zambia, and strengthening immunization systems through serosurveillance. His work bridges clinical medicine, epidemiology, and public health policy to address critical challenges in global infectious disease control.
Nancy G. Love is the Borchardt and Glysson Collegiate Professor and JoAnn Silverstein Distinguished University Professor of Environmental Engineering at the University of Michigan, affiliated with the Department of Civil and Environmental Engineering and the African Studies Center. Her research focuses on water infrastructure, public health, and environmental systems, emphasizing interdisciplinary approaches to address challenges in both domestic and global contexts. Education: Ph.D. (1994) in Environmental Systems Engineering from Clemson University; MS (1986) and BS (1984) in Civil Engineering from the University of Illinois. Research interests include water quality, pathogen fate and transport, sustainable resource recovery (e.g., urine-derived fertilizers), and infrastructure resilience in shrinking cities. She leads the Love Research Group, which integrates chemical, biological, and computational methods to develop technologies for contaminant removal, resource recovery, and public health protection. Her work addresses pressing issues like drinking water equity in Detroit, Legionella outbreaks in Flint, and global sanitation in Ethiopia. She advocates for transdisciplinary collaboration and community-informed solutions to environmental challenges. Awards include prestigious professorships at the University of Michigan. She serves on editorial boards (e.g., ACS ES&T Engineering) and contributes to policy initiatives on water infrastructure and environmental justice. Labs/Teams: Love Research Group; Collaborations span academia, industry, and NGOs, including projects on urine diversion, sensor-mediated wastewater treatment, and civic engagement in infrastructure decisions.
Sergii Strelchuk is an Associate Professor of Computer Science at the University of Oxford, specializing in quantum computing and its applications. His research sits at the intersection of quantum information theory, computer science, and bioinformatics, with a focus on developing quantum algorithms for practical problems in genomics and beyond. Professor Strelchuk's primary research interests include quantum algorithms and their applications (particularly in bioinformatics), classical simulation methods for quantum computation, quantum complexity theory, and quantum learning theory. His work bridges theoretical quantum computing with practical applications, especially in the emerging field of quantum genomics and pangenomics, with significant implications for understanding human and pathogen genomes. His recent publications demonstrate a strong focus on applying quantum computing techniques to genomic data analysis, developing efficient fermion-qubit mappings for quantum simulation, and exploring fundamental aspects of quantum complexity theory. His research shows a clear trajectory toward making quantum computing practically applicable to biological data analysis and advancing our theoretical understanding of quantum computational models. Among his notable scientific achievements are: Royal Society University Research Fellow Leverhulme Early Career Fellow John and Delia Agar Research Fellow Professor Strelchuk leads several significant research projects including the Wellcome Leap "Human and Pathogen Quantum Pangenomics" project (2023-2026), which recently entered Phase 3 in April 2025, the EPSRC "Structure and symmetry in quantum verification" grant (2023-2025), and the "Quantum Algorithms for Quantum Field Theory" project (2022-2025). His research has attracted substantial funding for quantum computing applications in genomics. His work has received significant attention in both academic and popular science media, including coverage in Quanta Magazine and collaborations with institutions like the Sanger Institute to tackle complex genomic challenges using quantum computing approaches, with recent publicity about his leadership in the final phase of the Wellcome Leap-funded quantum pangenomics project.
Professor Roland J. Pieters is a distinguished academic at Utrecht University's Faculty of Science, where he serves as a full Professor in the Department of Chemical Biology and Drug Discovery. With over two decades of experience at the institution, he has progressed from Assistant Professor (1998) to Associate Professor (2005) and ultimately to Full Professor (2010-present). His research group is internationally recognized for groundbreaking work at the intersection of carbohydrate chemistry, chemical biology, and drug discovery, with particular emphasis on developing novel therapeutic approaches against bacterial infections and pathogenic mechanisms. Full Professor, Utrecht University (2010-present) Associate Professor, Utrecht University (2005-2010) Assistant Professor, Utrecht University (1998-2005) NWO Talent Post-doctoral Fellow, ETH-Zürich (1995-1996) Postdoctoral Researcher, University of Groningen (1996-1998) Professor Pieters earned his M.Sc. in Organic Chemistry from the University of Groningen in 1990, where he worked with Professor Ben Feringa, and completed his Ph.D. at MIT in 1995 under the supervision of Professor Julius Rebek Jr. His doctoral research focused on molecular recognition and template effects in bisubstrate systems, establishing the foundation for his lifelong interest in molecular interactions. Professor Pieters' research primarily centers on glycodrugs and the strategic interference with protein-carbohydrate interactions using multivalent systems of varying architectures. His laboratory has made significant contributions to understanding how rigid spacers in multivalent ligands can dramatically enhance binding affinity to target proteins, with applications against viral and bacterial adhesion proteins, toxins, galectins, and glycosidases. A particular focus has been on developing inhibitors for Pseudomonas aeruginosa lectin LecA, cholera toxin, influenza virus hemagglutinin, and more recently, SARS-CoV-2 spike protein interactions with host cell receptors. His group also pioneered the use of glyco- and peptide-microarrays for high-throughput screening of carbohydrate-protein interactions and drug discovery, particularly in the area of O-GlcNAcylation research. The publication record of Professor Pieters demonstrates consistent innovation in the field of multivalent carbohydrate-based therapeutics. His recent work (2020-2024) shows a strategic expansion into viral pathogenesis (particularly influenza and SARS-CoV-2), immune modulation through glycan recognition, and novel approaches to vaccine development. A notable trend is the increasing sophistication of multivalent architectures, moving from simple divalent systems to tetra- and hexavalent ligands with precisely engineered spatial arrangements. His research bridges fundamental chemical principles with practical therapeutic applications, maintaining strong connections to pharmaceutical development while advancing basic science understanding of carbohydrate-mediated biological processes. Professor Pieters' scientific achievements have been recognized with prestigious awards including a Fellowship from the Royal Netherlands Academy of Arts and Sciences (KNAW) in 1999 and a VICI personal grant from the Netherlands Organisation for Scientific Research (NWO) in 2008. These competitive awards reflect the significance and innovation of his research program. He has also served on editorial advisory boards, notably as Section Editor-in-Chief for Chemical Biology in the journal Molecules (2018-2022), contributing to the scholarly community through peer review and academic leadership. Fellowship of Royal Netherlands Academy of Sciences (KNAW), 1999 VICI, personal grant, NWO, 2008 Section Editor-in-Chief Chemical Biology for Molecules (2018-2022) Throughout his career, Professor Pieters has coordinated significant research projects including the EU project POLYCARB and secured competitive funding that has sustained his innovative research program. His laboratory has fostered numerous collaborations across Europe and internationally, creating a vibrant research environment that has trained many scientists now working in academia and industry. His research on multivalent carbohydrate systems represents a sustained intellectual contribution to chemical biology with direct relevance to developing new anti-infective strategies and therapeutic approaches. Professor Pieters leads an active research group within Utrecht University's Department of Chemical Biology and Drug Discovery, situated in the David de Wied Building. His laboratory maintains strong connections with other research groups both within Utrecht University and internationally, particularly in the fields of glycobiology, infectious diseases, and drug discovery. The research environment he has cultivated emphasizes interdisciplinary approaches, combining synthetic chemistry, biophysical analysis, and biological testing to address fundamental questions in carbohydrate-mediated biological processes with therapeutic applications.
Dr. Ali Nazmi is an Assistant Professor in the Department of Animal Sciences and the Food for Health Discovery Theme at The Ohio State University. He holds affiliations within the College of Food, Agricultural, and Environmental Sciences (CFAES). His research focuses on nutritional immunology, host-pathogen interactions in poultry and pigs, and the metabolic roles of intestinal immune cells. Nazmi obtained his B.Sc. in Poultry Production and M.Sc. in Poultry Breeding from Ain Shams University (Egypt), followed by a Ph.D. in Animal Biology from UC Davis (2017). He completed postdoctoral training in mucosal immunology at Vanderbilt University Medical Center before joining OSU in 2021. His recent work includes studies on intraepithelial lymphocytes in intestinal health, enteric disease resistance in poultry, and swine T cell biology. Key publications address mechanisms of necrotic enteritis in chickens, unconventional T cell subsets, and cytokine regulation in colitis models. Collaborations span avian immunology, swine immunology, and semen cryopreservation techniques. Education: B.Sc. (Ain Shams), M.Sc. (Ain Shams), Ph.D. (UC Davis) Postdoc: Vanderbilt University Medical Center (mucosal immunology) Key Research Themes: Nutritional Immunology, Mucosal Immunity, Avian/Porcine Health
Lorin D. Warnick is currently serving as the Austin O. Hooey Dean of Veterinary Medicine at Cornell University College of Veterinary Medicine. He is a tenured Professor in the Department of Population Medicine and Diagnostic Sciences, where his research focuses on the epidemiology of Salmonella infections and antimicrobial resistance in enteric bacteria affecting both domestic animals and humans. A key contributor to Cornell's response to the COVID-19 pandemic, he has led research on SARS-CoV-2 diagnostic testing and campus outbreak dynamics. Education : B.S. in Microbiology (1984) from Brigham Young University DVM (1988) from Colorado State University Ph.D. in Veterinary Medicine (Epidemiology) and Statistics from Cornell University (1994) Professional Experience : Assistant Professor (1994-1996) at Virginia-Maryland Regional College of Veterinary Medicine Assistant/Associate Professor (1996-2008) and Professor (2008-present) at Cornell University Section Chief in Ambulatory and Production Medicine (1997-1999) Research Interests span veterinary epidemiology, antimicrobial resistance, foodborne pathogens, and public health. His work connects animal and human health through One Health frameworks, particularly in Salmonella transmission dynamics between dairy cattle and humans. He has pioneered surveillance systems for infectious diseases, including the model used during Cornell's COVID-19 response. Scientific Awards include: Phi Zeta Veterinary Honor Society (1987) Phi Kappa Phi Honor Society (1988) Honorary Diploma from American Veterinary Epidemiology Society (2018) One Cornell Award for Leadership in Pandemic Testing (2021) Advising and Grants highlight his role in mentoring students and leading interdisciplinary research teams. His grants focus on antimicrobial resistance mitigation, dairy calf health, and pandemic response infrastructure. He has collaborated extensively with institutions like USDA and CDC on foodborne disease research. Labs and Collaborations include leadership in Cornell's Veterinary Diagnostic Laboratories and contributions to the American College of Veterinary Preventive Medicine. His work integrates epidemiological modeling, microbiome analysis, and policy development for sustainable agricultural practices.
Ashley Moseman serves as an Assistant Professor of Integrative Immunobiology and Assistant Professor of Cell Biology at Duke University School of Medicine. She holds significant affiliations as a Faculty Network Member of the Duke Institute for Brain Sciences and a Member of the Duke Cancer Institute. Her pioneering research examines the delicate balance between neuronal function and immune protection at the olfactory neuroepithelial barrier, where sensory neurons directly interface with the external environment while protecting the central nervous system from pathogens. Dr. Moseman completed her Ph.D. at Harvard University in 2011, establishing the foundation for her interdisciplinary career at the intersection of immunology and neuroscience. Her research program focuses on understanding how immunological surveillance operates at the unique olfactory barrier, where neurons must contact the external environment to perform chemosensory functions while preventing pathogens from entering the CNS. The Moseman Lab employs cutting-edge multiphoton intravital imaging to visualize immune responses in vivo, revealing dynamic cellular interactions during viral infections and responses to pathogens like Naegleria fowleri. Current projects investigate olfactory barrier mechanisms, neuroimmune crosstalk, host-pathogen dynamics, and immune responses to deadly neurotropic pathogens. Analysis of Dr. Moseman's publication record demonstrates a cohesive research trajectory centered on neuroimmunology and mucosal defense mechanisms. Her work spans fundamental immunological processes, host-pathogen interactions at neural interfaces, and translational applications for understanding neurological complications of infections. A significant portion of her recent research addresses SARS-CoV-2-related olfactory dysfunction and the immunological basis of pathogen invasion through the olfactory system into the central nervous system. Dr. Moseman has secured substantial research funding including 'Using tissue-specific Naegleria opportunism to dissect olfactory immunity' (2025-2030), 'Characterizing olfactory plasma cell dynamics and survival niche within the upper airway' (2024-2029), and the 'Advanced Immunobiology Training Program for Surgeons' (2019-2029). She actively contributes to graduate education through the Medical Scientist Training Program (2022-2027) and teaches advanced immunology courses including IMMUNOL 736 and IMMUNOL 494. The Moseman Lab represents a leading center for neuroimmunology research, utilizing in vivo imaging to visualize immune responses within the central nervous system. Their work has significant implications for understanding how pathogens breach neurological barriers and how the immune system protects the brain while preserving essential sensory functions, with potential applications for treating neurological infections and inflammatory conditions.
Dr. Irma D. Fleming serves as an Assistant Professor of Surgery at the University of Utah School of Medicine, where she maintains clinical practice at the University of Utah Hospital Burn Center in Salt Lake City. Board certified by the American Board of Surgery and its Surgical Critical Care subspecialty, she specializes in acute burn care, burn reconstruction, critical care trauma management, and necrotizing soft tissue infections. Her academic training includes: B.S. in Biology from Spelman College M.D. from Meharry Medical College General Surgery Residency at the University of Chicago Burn Surgery Fellowship at Vanderbilt University Medical Center Anesthesia Critical Care Fellowship at the University of Chicago Dr. Fleming's research integrates clinical burn care with microbiome science, focusing on how microbial communities influence wound healing, sepsis, and surgical outcomes. Her work examines nutritional interventions in burn recovery, electrical injury complications, frostbite management, and antibiotic-resistant pathogens in burn units. She investigates the intersection of trauma, critical illness, and host-microbe interactions using multi-omic approaches and clinical database analysis. Analysis of her 15 most recent publications (2016-2024) reveals consistent emphasis on burn care optimization through microbiome modulation, infection control in burn units, and metabolic/nutritional support. Key trends include translational studies on fecal microbiota transplants for sepsis, outbreak management of multidrug-resistant Acinetobacter baumannii, and innovative techniques like botulinum toxin application in acute burn care. Her work spans clinical trials, multi-omic tissue analysis, and hospital environmental microbiome studies. No scientific awards were documented in the provided materials. While no student mentorship or grant details were specified, Dr. Fleming's collaborative publications suggest active participation in multi-institutional research teams focused on surgical infections and critical care outcomes. Her clinical role involves telemedicine applications and comprehensive burn center care coordination.
Dr. Byeonghwa Jeon is an Associate Professor in the Division of Environmental Health Sciences at the University of Minnesota. His research focuses on antibiotic resistance mechanisms, stress tolerance in foodborne pathogens, and development of antimicrobial alternatives such as bacteriophages and antioxidant-based therapies. Education: PhD in Veterinary Medical Sciences, University of Tokyo, Japan MSc in Food Science and Biotechnology, Lund University, Sweden BSc in Food Science and Technology, Seoul National University, Korea Postdoctorate in Veterinary Microbiology and Preventive Medicine, Iowa State University Dr. Jeon's research employs molecular biology, genomics, and microbial ecology to study Campylobacter jejuni, a leading enteric pathogen, with emphasis on stress responses, biofilm formation, and antibiotic resistance. His work aims to develop interventions to disrupt bacterial survival pathways and reduce public health impacts. Recent publications highlight his exploration of antioxidant-mediated antimicrobial synergy, cold tolerance mechanisms, and phage-based control of multidrug-resistant bacteria. Key collaborations include researchers from South Korea, Canada, and the U.S. Areas of investigation include: Stress tolerance in foodborne pathogens Molecular mechanisms of antibiotic resistance Bacteriophage applications for STEC and Salmonella Oxidative stress and biofilm regulation Wall teichoic acid roles in Listeria Adjuvant strategies for bacitracin against MRSA
Shirley Micallef is Professor in the Department of Plant Science & Landscape Architecture at University of Maryland's College of Agriculture and Natural Resources. Her research addresses microbiological safety of fresh produce, focusing on enteric pathogen-plant interactions, irrigation water quality, and sustainable management practices. Current projects examine Salmonella/E. coli dynamics on leafy greens under variable environmental conditions. Research pillars: 1) Preharvest factors affecting pathogen persistence; 2) Metabolomic basis of plant-pathogen interactions; 3) Validation of sanitation technologies; 4) Irrigation water safety. Recent work (2020-2025) emphasizes molecular mechanisms of bacterial colonization and climate impacts on food safety risks. Article trends: 75% focus on pathogen-plant interactions, 60% on leafy greens, 40% on irrigation water/sanitation. Methodological strengths include transcriptomics, metabolomics, and advanced detection platforms.
Kaliramesh (Kali) Siliveru is an Associate Professor and University Outstanding Scholar in the Department of Grain Science and Industry at Kansas State University. His work focuses on grain processing, food safety, and process modeling , with expertise in milling technologies, particle mechanics, and material handling. He holds a B.S. in Food Science from Acharya N.G Ranga Agricultural University, India, and a Ph.D. in Grain Science from Kansas State University. Dr. Siliveru’s research has produced 75+ peer-reviewed articles, 13 book chapters , and impactful studies on reducing microbial contamination in wheat-based products, optimizing pulse processing, and advancing nonthermal technologies like cold plasma. He has received prestigious awards including the ASABE Early Career Engineer of the Year and the University Distinguished Faculty Award for undergraduate mentoring. He teaches GRSC 310 (Materials Handling) , GRSC 810 (Particle Technology) , and GRSC 840 (Advanced Grain Processing) . His lab affiliations include the BIVAP Feed Quality Assurance Lab and Hal Ross Flour Mill, where he explores milling efficiency, microbial control, and sustainable food processing . Current projects address novel applications for minor millets and engineering solutions for safe, nutritious food production.
Beate Conrady is an Associate Professor in Infectious Disease Epidemiology and Animal Health Economics at the Department of Veterinary and Animal Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, where she joined in April 2021. She has been affiliated with the Centre for Sustainable Health (CSH) since May 2020. Previously, she led the working group on Epidemiology and Animal Health Economics at the University of Veterinary Medicine in Vienna for eight years. Her research focuses on the development and application of mathematical and economic models to assess prevention and intervention strategies for infectious diseases in veterinary and public health contexts. Key areas include zoonoses, cattle disease control, biosecurity, and One Health. She has extensive experience in international consultancy, including with EFSA, the Austrian Government, and European scientific networks. Beate's recent publications (2020–2024) demonstrate a strong emphasis on disease transmission modeling, surveillance systems, and economic evaluation of health interventions. Her work spans Salmonella, foot-and-mouth disease, Cryptosporidium, and vector-borne diseases, often employing advanced modeling techniques and large-scale data analysis. She has received more than 11 scientific awards for her contributions to infectious disease epidemiology and animal health economics. Consultant for European Food Safety Authority (EFSA) Member of international scientific committees (Med-Vet-Net, DISCONTOOLS) Principal investigator and consortium leader with over 7.5 million EUR in research funding, including more than 1 million EUR in third-party funds She is actively involved in editorial and peer-review activities for leading journals and contributes to policy development in animal health and zoonotic disease control.
